Granules Pharmaceuticals receives FDA tentative approval for gDYANAVEL XR EP News Bureau Jan 9, 2026 Granules Pharmaceuticals, a wholly owned subsidiary of Granules India, has received tentative approval (TA) from the US Food and…
